All Stories

  1. Machine learning-based optimization of the prostate health index for prostate cancer detection
  2. Cytopenias as Adverse Drug Reactions: A 10-Year Analysis of Reporting Structure, Rate, and Trend
  3. Enhancing the Prediction of Clinically Significant Prostate Cancer Through Feature Engineering
  4. Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence
  5. Clinical advances in investigational epilepsy treatments
  6. Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union
  7. A Case of Paradoxical Appetite Increase During Semaglutide Therapy
  8. Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review
  9. Factors Affecting Thyroid Volume in Children Aged 4 to 18 Years
  10. Cost–utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle‐income economy setting
  11. Cost Analysis of Hospital Treatment for Peritoneal Dialysis-Associated Peritonitis
  12. Nonchemotherapy drug‐induced cytopenias: A cost‐of‐illness study using the microcosting methodology based on real‐world data
  13. Predictive clinical characteristics for adverse pathological outcomes in intermediate- and high-risk prostate cancer during biopsy
  14. Safety Profile of Antipsychotics as Predictors of the Quality of Life in Patients with Schizophrenia—An Inpatient Welfare Institution-Based Cross-Sectional Study
  15. Using validated model informed precision dosing for dose adjustment: superior evidence needed for efficacy and safety
  16. Clinical Pharmacokinetics and Pharmacodynamics of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
  17. 3D transesophageal echocardiography has benefits in the diagnosis and prognosis of patients with infectious endocarditis
  18. Preventable serious drug-disease interactions of reserve antibiotics
  19. Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models
  20. Risk factors for urinary tract infection and asymptomatic bacteriuria after stroke
  21. Analysis of Reporting Trends of Serious Adverse Events Associated With Anti‐Obesity Drugs
  22. Translation to Serbian and Transcultural Adaptation of the Fraboni Scale of Ageism in a Population of Community Pharmacists
  23. ABCB1 Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
  24. Predicting intermediate-risk prostate cancer using machine learning
  25. Anthropometric Data by Using Bioelectrical Analysis as a Parameters for New Classification and Definition of Obesity
  26. Risk factors for severe adverse drug reactions in hospitalized patients
  27. Physiologically based pharmacokinetic and toxicokinetic modeling: A multidisciplinary approach to drug development and ecotoxicology
  28. Vitamin K epoxide reductase complex subunit 1 gene promoter polymorphism - a potential genetic basis for survival from thromboembolism in COVID-19
  29. Serious adverse effects of selected antiseizure medications used for treatment of focal onset seizures
  30. <em>ABCB1</em> Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
  31. Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature
  32. New Scale Measuring Willingness to Deliver Pharmaceutical Care to Elderly (WPhCAReELD Scale)
  33. Novel Insights into Amlodipine-Induced Gingival Enlargement: A Clinical and Molecular Perspective
  34. Population toxicokinetics of carbamazepine and its metabolite carbamazepine-10,11-epoxide in adults
  35. Predictors of Intrahospital Mortality in Aneurysmal Subarachnoid Hemorrhage after Endovascular Embolization
  36. Predictors Of Marketing Authorization Status Of Dipyrone Within A Country
  37. POPULATION PHARMACOKINETICS OF PANTOPRAZOLE IN PATIENTS ON DUAL ANTIPLATELET THERAPY FOLLOWING ACUTE CORONARY SYNDROME
  38. Validation of Novel High-Performance Liquid Chromatography Method for Meropenem Quantification in Plasma
  39. Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics
  40. Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Drug Interactions
  41. Factors Associated with Abnormal Uterine Bleeding in Perimenopausal Women
  42. Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional study
  43. Multidisciplinary teams in healthcare
  44. Add-on antihypertensives for treatment of resistant hypertension: An extension of the TRYCORT study
  45. Antiobesity drugs utilization trend analysis and reimbursement lists status: The perspective of selected European countries
  46. Biomarkers of inflammation and multisystem tissue and organ damage in patients with COVID-19
  47. Diagnostic agreement of presepsin, procalcitonin, C-reactive protein and white blood cell count in patients with suspected sepsis
  48. Improving estimate of cost/effectiveness of drugs for rare diseases
  49. Patient blood management: Team working between clinical transfusiology and clinical pharmacology
  50. Population pharmacokinetics of vancomycin in hemodialysis patients
  51. Long-term outcomes in refractory status epilepticus
  52. Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review
  53. Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis
  54. Factors affecting outcome in hospitalized patients treated according to recommendations from clinical pharmacologists
  55. Results of the trycort: Cohort study of add-on antihypertensives for treatment of resistant hypertension
  56. Enhanced PSA Density Prediction Accuracy When Based on Machine Learning
  57. Guidance for interactions between antiseizure medications
  58. Economic analysis of cerliponase alfa for treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)
  59. Healing Factors of Decubital Lesions in Denture Wearers
  60. SGLT2 Inhibitors: A Systematic Review for Heart Failure Treatment
  61. Investigational new drugs for the treatment of Dravet syndrome: an update
  62. Predictors of Mortality in Early Neonatal Sepsis: A Single-Center Experience
  63. Hypovitaminosis D in infants: Evidence that increased intake of vitamin D reduces the incidence of allergic and respiratory disorders
  64. Psychometric Properties of the Persian Version of Fear of Hospitalization Scale in Patients Undergoing Emergency Surgery
  65. Testing of new instrument for measuring quality and diversity of nutrition in pregnancy
  66. Acute toxicity threshold of normobaric oxygen therapy: Systematic review
  67. Population Pharmacokinetic Modeling to Inform Sertraline Dosing Optimization in Patients with Depression
  68. Kounis Syndrome Associated With the Use of Diclofenac
  69. Mirtazapine-induced Acute Pancreatitis in Patients With Depression: A Systematic Review
  70. Improved Prediction of Significant Prostate Cancer Following Repeated Prostate Biopsy by the Random Forest Classifier
  71. Meta‐analysis of peripheral insulin‐like growth factor 1 levels in schizophrenia
  72. Factors Associated with Potentially Inappropriate Prescribing in Patients on Peritoneal Dialysis
  73. Review of compounds that exhibit radioprotective and/or mitigatory effects after application of diagnostic or therapeutic ionizing radiation
  74. Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: systematic review
  75. Clinical Pharmacokinetics and Pharmacodynamics of Esaxerenone, a Novel Mineralocorticoid Receptor Antagonist: A Review
  76. Advancements in neuroactive peptides in seizures
  77. Reduction of direct and indirect costs of treatment of patients with type 2 diabetes due to good glycemic control and reduced frequency of complications
  78. Risks factors of prolonged hospitalization in COVID-19 patients
  79. Toxic megacolon after irrational antibiotic treatment of pregnat patient with Covid 19: Case report
  80. Improved predictive performance of prostate biopsy collaborative group risk calculator when based on automated machine learning
  81. Novel and emerging therapeutics for genetic epilepsies
  82. Antimicrobial treatment of Morganella morganii invasive infections: Systematic review
  83. Effects of Supplementation in Vitamin D3 Deficient or Insufficient Children with Allergic Diseases
  84. Personalization of drug dose thematic issue: introduction article
  85. Risk factors for potential drug–drug interactions in patients with myasthenia gravis
  86. Treating of focal epilepsy: a patent review
  87. <b>Quality of Life Assessment in Type 2 Diabetes Patients With Cardiovascular and/or Diabetic Complications</b>
  88. Does the Severity of Obstructive Sleep Apnea Have an Independent Impact on Systemic Inflammation?
  89. New instrument for measuring quality of life in patients with cervical cancer
  90. Characteristics of COPD Phenotypes in Serbia
  91. Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy
  92. Inflated Co-authorship Introduces Bias to Current Scientometric Indices
  93. Accuracy of serum procalcitonin, C-reactive protein and soluble CD14 subtype levels in diagnosis of sepsis in children
  94. DRESS syndrome without eosinophilia induced by Carbamazepine: A case report
  95. Focus group and Delphi process: Stroke and potential drug-drug Interactions (pDDI) in the neurological Intensive Care Unit (NICU)
  96. Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases
  97. Method for adjusting results of pharmacoeconomic studies from country to country using Bayesian statistics
  98. Risk factors for potential drug-drug interactions in a general neurology ward
  99. The QTc interval and treatment outcome of inpatients with COVID-19
  100. Epidemiology and risk factors for healthcare-associated infections caused by Pseudomonas aeruginosa
  101. Lessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts?
  102. Risk factors for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage
  103. Adaptation of the prostate biopsy collaborative group risk calculator in patients with PSA less than 10 ng/ml improves its performance
  104. Association of PC and AT levels in the early phase of STEMI treated with pPCI with LV systolic function and 6-month MACE
  105. Evaluation of zonisamide for the treatment of focal epilepsy: a review of pharmacokinetics, clinical efficacy and adverse effects
  106. Predictors of antibiotic utilization among intensive care unit patients
  107. Antiviral therapy of COVID-19
  108. Drug rash with eosinophilia and systemic symptoms syndrome in an adolescent - efficiency of immunoglobulin G in a corticosteroid resistant case
  109. Efficacy and safety of triazoles versus echinocandins in the treatment of invasive aspergillosis: A meta-analysis
  110. Geopolitical thought in the Apennine peninsula: Teachers and students
  111. Risk factors for healthcare-associated infections caused by cefepime-resistant Pseudomonas aeruginosa
  112. Translation to Serbian and transcultural adaptation of the oral health-related quality of life [OHQoL-UK(W)] instrument
  113. The Basic Principles of Editing Biomedical Scientific Journals
  114. Correlation between laboratory parameters and COVID-19 treatment outcome
  115. Local guidelines for drug treatment of patients with COVID-19
  116. Surgical Fear Questionnaire (SFQ) - Serbian cultural adaptation
  117. The reasons for development of complications in soft contact lenses wearers: A qualitative study
  118. Editing Medical Journals B
  119. Optimal threshold of the prostate health index in predicting aggressive prostate cancer using predefined cost–benefit ratios and prevalence
  120. Efficacy and safety of local lysozyme treatment in patients with oral mucositis after chemotherapy and radiotherapy
  121. A Critique of Pharmacokinetic Calculators for Drug Dosing Individualization
  122. Contemporary surgical management of drug-resistant focal epilepsy
  123. Cost-utility of tafenoquine vs. primaquine for the radical cure (prevention of relapse) of Plasmodium vivax malaria
  124. Screening general practice patients for migraine without aura: construction and validation of the Balkan Migraine Screening Questionnaire (BMSQ)
  125. Antimicrobial treatment of Kocuria kristinae invasive infections: Systematic review
  126. Effects of local guidelines on prescribing practice and treatment outcomes in a long-stay psychiatric facility
  127. Pandrug-resistant Pseudomonas aeruginosa isolated from qualitative endotracheal aspirate could rather be contaminant than causative agent of respiratory infections in intensive care unit patients: Case study
  128. Predictors of potential drug-drug interactions in patients at intensive care unit
  129. Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
  130. Development and validation of a questionnaire for measuring drug-induced nausea
  131. Factors influencing extent of nausea in the patients on oral iron therapy
  132. Performance of a calculator for diagnosing the cause of liver damage
  133. Psychometric properties of the Headache Under-Response to Treatment (HURT) questionnaire and the Migraine Disability Assessment Test (MIDAS) translated to Serbian
  134. Where next for antiepileptic therapeutic drug monitoring?
  135. Antimicrobial Activity of Aqueous Extracts of Potentilla Reptans L. Rhizome and Aerial Part
  136. Drug–drug interactions in patients receiving hematopoietic stem cell transplantation
  137. Drug–drug interactions in patients with acute coronary syndrome across phases of treatment
  138. Pharmacokinetics of vancomycin in patients with different renal function levels
  139. Profile of evolocumab and its cost-effectiveness in patients with high cardiovascular risk: literature review
  140. Investigational cannabinoids in seizure disorders, what have we learned thus far?
  141. Correlation between cefepime utilisation and Pseudomonas aeruginosa resistance rates to β-lactams and carbapenems in patients with healthcare-associated infections
  142. A questionnaire to measure how much a patient is afraid of being admitted to a hospital.
  143. A Questionnaire for Assessing Fear of Radiotherapy in Oncology Patients
  144. Delirium Risk Factors in Elderly Patients Suffering from Femoral Neck Fractures
  145. Problems with the Administration of Antipsychotic Drugs in Depot Formulations in the Treatment of Schizophrenia
  146. Analysing factors which influence treatment outcomes by multivariable linear regression
  147. Calculation of drug dose which produces 'all-or-nothing' response in 50% of subjects (effective dose 50) using probits
  148. The role of a pharmacist in prevention and detection of OTC drug interactions: Nominal group technique
  149. Modern approach to the therapy of infections caused by Clostridium difficile
  150. Risk factors for nosocomial infections in mechanically ventilated neonates at intensive care unit
  151. Alarm system for surveillance of patients receiving high doses of radioiodine (131I) therapy in the case of unauthorised abandoning of a controlled area
  152. The study of the Middle East in the Journal International Problems between 1950 and 1990
  153. Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs
  154. Evaluation of brivaracetam: a new drug to treat epilepsy
  155. Population Pharmacokinetic Analysis of Bisoprolol in Patients with Stable Coronary Artery Disease
  156. Factors Influencing the Fear of Needles among Students of Medicine and Pharmacy
  157. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit
  158. Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children
  159. Translation, Cultural Adjustment and Evaluation of Reliability and Validity of “Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form” for Patients with Schizophrenia
  160. Psychometric Development of Chemotherapy Side Effects Fear Scale
  161. Development and Validation of the Questionnaire for the Evaluation of Knowledge about Herbal Preparations (QEK-HP)
  162. Factors associated with the rate of COPD exacerbations that require hospitalization
  163. Antiepileptic potential of ganaxolone
  164. Translation to Serbian, cultural adaptation, reliability testing and validation of the questionnaire estimating the fear of injections
  165. Reslizumab versus placebo for poorly controlled, severe eosinophilic asthma: Meta-analysis
  166. Clinical and laboratory parameters associated with death in acute pancreatitis
  167. Predictors of involuntary hospitalisation of patients suffering from schizophrenia
  168. Effects of antidepressants on serum concentrations of bone metabolism markers and major electrolytes in patients from routine psychiatric practice
  169. Hospital infections rate and health staff density in a Neonatology Department
  170. Translation to Serbian, Transcultural Adaptation and Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM- ICU)
  171. Risk factors for hospital infections caused by carbapanem-resistant Acinetobacter baumannii
  172. Consulting clinical pharmacologist about treatment of inpatients in a tertiary hospital in Serbia
  173. Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications
  174. Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary Syndrome
  175. Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis
  176. The psychometric properties of the Comprehensive Headache-related Quality of life Questionnaire (CHQQ) translated to Serbian
  177. The impact of cardiovascular drugs on the efficacy of local anesthesia in dentistry
  178. Effects of cardiovascular drugs on TSH serum levels in patients on replacement therapy after thyroidectomy
  179. Pharmacokinetics of linezolid in critically ill patients
  180. CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy
  181. Population Pharmacokinetics of Bisoprolol in Hemodialysis Patients with Hypertension
  182. Analysis of Treatment-Related Factors Affecting Mortality in Patients with Severe Necrotizing Acute Pancreatitis
  183. Hospital-Acquired Pneumonia in Newborns with Birth Weight Less Than 1500 Grams: Risk Factors and Causes
  184. Developmentand Validation of a Questionnaire about Patient Knowledge of Adverse Effects of Statins
  185. Measuring Potential of Preschool Facility Staff to Prevent Early Childhood Caries
  186. Neutropenia induced by non-cytotoxic drugs
  187. Headache in patients undergoing general anesthesia
  188. Drug-related problems in patients with osteoporosis
  189. Frequency of headache in oncology patients undergoing radiotherapy
  190. Factors affecting inappropriate prescription of antibiotics and the emergence of antibiotic resistance in patients in primary health care
  191. Factors influencing knowledge transfer from faculty to PhD students
  192. Factors associated with early treatment failure in adult hospitalized patients with community-acquired pneumonia
  193. Markers of inflammation as risk predictors of lethal outcome in patients diagnosed with delirium
  194. Risk factors for healthcare-acquired urinary tract infections caused by multi-drug resistant microorganisms
  195. Etiology and resistance patterns of bacteria causing ventilator-associated pneumonia in a medical intensive care unit
  196. Parameters of Calcium Metabolism Fluctuated during Initiation or Changing of Antipsychotic Drugs
  197. Quality of life in patients early after surgery
  198. Neuroleptic malignant syndrome: the diagnostic dilemma
  199. Community-acquired urinary tract infections: Causative agents and their resistance to antimicrobial drugs
  200. Cost effectiveness comparison of dutasteride and finasteride in patients with benign prostatic hyperplasia - the Markov model based on data from Montenegro
  201. The importance of early recognition and timely treatment of delirium in intensive care units
  202. Measuring Patientsʼ Knowledge About Adverse Effects of Angiotensin-Converting Enzyme Inhibitors
  203. Vectors of Turkish foreign policy: What remains of the strategy for 2023?
  204. P-Glycoprotein Polymorphism C3435T Is Associated with Dose-Adjusted Clopidogrel and 2-Oxo-Clopidogrel Concentration
  205. MANAGEMENT OF CLINICALLY CURED TONSILLOPHARYNGITIS IN PATIENTS WITH GROUP A STREPTOCOCCUS ISOLATED FROM A PHARYNGEAL SWAB
  206. IMPROVING ANTIPSYCHOTICS PRESCRIBING BY PHARMACEUTICAL CARE
  207. Risk factors for potentially inappropriate prescribing to older patients in primary care
  208. Epidemiology and Treatment Guidelines of Negative Symptoms in Schizophrenia in Central and Eastern Europe: A Literature Review
  209. Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter
  210. THYRPAN-TM Prototype: New System for Online Telemonitoring of Patients with Thyroid Carcinoma During the Treatment with a High Dose of Radioiodine
  211. Predictors of Length of Stay in Patients with Spinal Cord Injury
  212. The use of dry Jerusalem artichoke as a functional nutrient in developing extruded food with low glycaemic index
  213. Analiza efektywności kosztowej terapii dronedaronem w porównaniu z leczeniem amiodaronem, propafenonem i sotalolem w grupie chorych z migotaniem przedsionków: wyniki badania przeprowadzonego w Serbii
  214. Variability of mycophenolic acid elimination in the renal transplant recipients – population pharmacokinetic approach
  215. Evolution of the Serbian pharmaceutical market alongside socioeconomic transition
  216. Reasons for Inadequate Vaccination after Splenectomy
  217. Perifocal oedema after endovascular embolization
  218. Early Cytokine Profile Changes In Interstitial And Necrotic Forms Of Acute Pancreatitis
  219. CYP3A5 Polymorphism In Serbian Paediatric Epileptic Patients On Carbamazepine Treatment
  220. Risk Factors For Development Of Acute Necrotizing Pancreatitis
  221. Quality Of Life Among Patients With Depression
  222. Lack Of PRSS1 And SPINK1 Polymorphisms In Serbian Acute Pancreatitis Patients
  223. Treatment of hypokalemia
  224. Drug-induced immune thrombocytopenia
  225. Drug treatment and prevention of postoperative headache
  226. Prevention and treatment of postoperative vomiting
  227. Calcitonin Gene-Related Peptide Receptor Blocker Inhibits Spontaneous Activity of Human Ureter
  228. Transplantation through the ages
  229. Adjuvant drug therapy of bleeding from gastric or duodenal ulcer
  230. Costs of benign prostatic hyperplasia treatment in Montenegro
  231. Analysis of the costs of treating dry socket
  232. Cognitive status of persons under guardianship living in a social welfare institution
  233. Analysis of risk factors for occlusions of a synthetic femoropopliteal bypass graft
  234. Improving clinical drug development regulatory procedures for anticonvulsants
  235. Assessment of the reliability of the Serbian version of the sickness impact profile questionnaire in patients with chronic viral hepatitis
  236. Long-term treatment with olanzapine in hospital conditions: Prevalence and predictors of the metabolic syndrome
  237. Cost-effectiveness of depressive episode pharmacological treatment
  238. Risk factors for the development of metabolic syndrome in obese children and adolescents
  239. Impact of educational intervention on prescribing inappropriate medication to elderly nursing homes residents
  240. Population pharmacokinetics of 25-hydroxyvitamin D in healthy young adults
  241. Health care–acquired infections in neonatal intensive care units: Risk factors and etiology
  242. Attitudes of PhD students towards qualitative research methods in medicine
  243. Interaction between tigecycline and human serum albumin in aqueous solution
  244. generic versus brand anticonvulsants
  245. Rational therapy publication rate correlates with wealth of a society
  246. Cost-Effectiveness Comparison of Fidaxomicin and Vancomycin for Treatment of Clostridium difficile Infection: A Markov Model Based on Data from a South West Balkan Country in Socioeconomic Transition
  247. Pharmacokinetics of selective β1-adrenergic blocking agents: prescribing implications
  248. Comparison of EMA and FDA guidelines for drug interactions: An overview
  249. Hypocalcaemia: Causes, diagnostics and treatment
  250. Prescribing Antipsychotics in Montenegro: a Focus Group Analysis
  251. Medical emergencies facing general practitioners: Drugs for the doctor's bag
  252. Prevalence and predictors of potential drug-drug interactions
  253. The effects of microwave radiation on microbial cultures
  254. The Influence of Antipsychotics on the Quality of Life of Patients with Schizophrenia in a Long-stay Psychiatric Facility
  255. Risk factors for severe dental anxiety among medical students
  256. Comparative analysis of the chemical composition and antimicrobal activities of some of Lamiaceae family species and Eucaliptus (Eucaliptus globules M)
  257. Cost-effectiveness analysis of tocilizumab in combination with methotrexate for rheumatoid arthritis: A Markov model based on data from Serbia, country in socioeconomic transition
  258. Preparation, characterization and antimicrobial activity of chitosan microparticles with thyme essential oil
  259. Analysis of the Factors Influencing Functional Outcomes in Patients with Spinal Cord Injury
  260. Direct medical costs of COPD diagnosis and treatment, Eastern vs Western European country – examples of Serbia and Belgium
  261. Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: Sensitivity to antibiotics and risk factors
  262. Inverse correlation of Acinetobacter spp. resistance rate and ciprofloxacin utilization
  263. Influence of dialysis modality and membrane flux on insomnia severity in haemodialysis patients
  264. The preclinical discovery and development of ezogabine for the treatment of epilepsy
  265. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection in a tertiary care hospital in Serbia
  266. Population Pharmacokinetics of Carvedilol in Patients with Congestive Heart Failure
  267. Captopril May Influence Tone of Human Oviduct Ampulla
  268. An inverse correlation between TNF alpha serum levels and heart rate variability in patients with heart failure
  269. PhD Students’ Awareness of Research Misconduct
  270. Evernia prunastri and Pseudoevernia furfuraceae lichens and their major metabolites as antioxidant, antimicrobial and anticancer agents
  271. Cushing’s syndrome diagnosed after delivery: a case report
  272. Adequate doctor - patient communication
  273. Population pharmacokinetic of antiepileptic drugs in different populations
  274. A report of a medication error: Drug incompatibility
  275. Cardiotoxicity of Palladium Compounds / Kardiotoksičnost Jedinjenja Paladijuma
  276. Submissiveness to health authorities as an obstacle to practicing evidence based medicine
  277. Profile of urinary tract infections pathogens and their antimicrobial resistance patterns during three-year period (2009-2011) in the Clinical center Kragujevac
  278. Rituximab for the treatment of rheumatiod arthritis patients with failure to the first biologic drug: Impact on Republic fund for health insurance in Serbia
  279. Zuclopenthixol decanoate in pregnancy: Successful outcomes in two consecutive off springs of the same mother
  280. Risk factors for lethal outcome in patients with delirium tremens - psychiatrist's perspective: a nested case-control study
  281. Comparative analysis of the chemical composition of Heliantus tuberosus L. growing in Serbia and Romania
  282. Comparison of three methods used for measurement of radioiodine fixation in thyroid gland of mice
  283. Hospital infections in a neurological intensive care unit: incidence, causative agents and risk factors
  284. Population pharmacokinetics of bisoprolol in patients with chronic heart failure
  285. Effects of aurothiomalate and gold(III) complexes on spontaneous motility of isolated human oviduct
  286. Online Remote Monitoring of Patients with Differentiated Thyroid Carcinomas and Neuroendocrine Tumors Treated with High Doses of Radionuclides
  287. Chemical and Antimicrobial Evaluation of Supercritical and Conventional Sideritis scardica Griseb., Lamiaceae Extracts
  288. Toxic Effects of Palladium Compounds on the Isolated Rat Heart
  289. Utilization of non-steroidal anti-inflammatory drugs in General and Endocrine Surgery Ward at Clinical Center 'Kragujevac' in Kragujevac
  290. Factors associated with hospitalization of children with acute odontogenic infections
  291. Factors associated with death in intensive care unit patients with ventilator-associated pneumonia
  292. Role of anticonvulsant therapeutic drug monitoring in improving clinical outcomes: An example of 12 adult epilepsy patients
  293. Secondary complications and associated injuries in traumatic and non-traumatic spinal cord injury patients
  294. Demographic characteristics and functional outcomes in patients with traumatic and nontraumatic spinal cord injuries
  295. Secondary complications and associated injuries in traumatic and non-traumatic spinal cord injury patients
  296. Risk factors for behavioural and emotional disorders in children with mild intellectual disability
  297. Predictors of pressure ulcers in patients with spinal cord injuries
  298. Risk factors for behavioural and emotional disorders in children with mild intellectual disability
  299. Effects of a Facebook profile devoted to drug use in pregnancy on the discovery of inappropriate drug use by pregnant females in the former Yugoslav republics
  300. Effects of a Facebook profile devoted to drug use in pregnancy on the discovery of inappropriate drug use by pregnant females in the former Yugoslav republics
  301. Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects
  302. Changes of platelets’ function in preeclampsia
  303. N-acetyltransferase-2 (NAT2) Gene Polymorphisms and Enzyme Activity in Serbs: Unprecedented High Prevalence of Rapid Acetylators in a White Population
  304. Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis
  305. Gallbladder Emptying in Patients with Major Depression: A Case Series
  306. Knowledge of the pharmacological profile of a patient improves the quality of prescribing, the outcomes of treatment, and the utilization of health services in primary health care
  307. Using Facebook to Increase Spontaneous Reporting of Adverse Drug Reactions
  308. Embolization of ruptured intracranial aneurysms with detachable coils: case series
  309. Effects of Methyldopa and Nifedipine on Uteroplacental and Fetal Hemodynamics in Gestational Hypertension
  310. Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors
  311. Electrolyte disorders associated with risperidone in psychotic patients
  312. Quality of life in patients with multiple sclerosis
  313. Metabolic syndrome in children and adolescents
  314. Of the phytochemical research performed to date on sideritis species
  315. The methodology of determining antibacterial activity of plant extracts with disk-diffusion method in vitro
  316. Risk factors for early postoperative arrhythmias in general surgery patients after general anesthesia
  317. Differentiation between opiate addicts in relation to judicial problems
  318. Adverse events induced by anti-infectives in hospitalized patients
  319. Attitudes towards antipsychotic drugs and their side effects: A comparison between students of medicine in Spain and Serbia
  320. Quality of life of schizophrenic patients treated with haloperidol depot and injection preparation of long-lasting risperidone
  321. Comparison of two different types of hormone therapy effects on haemostatic parameters in early postmenopausal women
  322. Non-invasive screening: The probability of events
  323. Resistance rates of Pseudomonas aeruginosa and Acinetobacter species causing ventilator-associated pneumonia do not always correlate with utilisation of antibiotics
  324. Risperidone-Associated Hypocalcemia
  325. Factors influencing valproate pharmacokinetics in children and adults
  326. Aliskiren and angioedema
  327. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism
  328. Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
  329. In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population
  330. Pharmacokinetic modelling of valproate in epileptic patients
  331. Antihypertensive drugs utilisation and educational activities
  332. Risk factors for recurrent vulvovaginal candidiasis
  333. A Nonlinear Mixed Effects Modelling Analysis of Topiramate Pharmacokinetics in Patients with Epilepsy
  334. The contractile effects of endothelins on isolated isthmic segment of human oviduct at the luteal phase of the menstrual cycle
  335. Monitoring of drug-associated electrolyte disturbances in a hospital
  336. Unexpected Effect of Furosemide on Radioiodine Urinary Excretion in Patients with Differentiated Thyroid Carcinomas Treated with Iodine 131
  337. Effects of Exogenous Glutamate and Kainate on Electric Field-stimulated Contractions of Isolated Human Ureter
  338. Costs of Rheumatoid Arthritis in a Balkan Country (Serbia)
  339. Renal transplantation vs hemodialysis: Cost-effectiveness analysis
  340. Significance of herbal drugs legislation for their rational use
  341. Assessment of diabetes mellitus type 2 treatment costs in the Republic of Serbia
  342. Current clinical evidence on topiramate pharmacokinetics
  343. Cost-effectiveness of four immunomodulatory therapies for relapsingremitting multiple sclerosis: A Markov model based on data a Balkan country in socioeconomic transition
  344. Contractile effects of endothelins on isolated ampullar segment of human oviduct in luteal phase of menstrual cycle
  345. Effects of cisplatin and other Pt(II) complexes on spontaneous motility of isolated human oviduct
  346. Risk factors for treatment failure in renal suppurative infections
  347. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy
  348. Cost-Effectiveness of Ritodrine and Fenoterol for Treatment of Preterm Labor in a Low–Middle-Income Country: A Case Study
  349. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients
  350. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes
  351. Utilization rate of carbapenems at intensive care units is not major determinant of gram-negative bacteria resistance to these antibiotics
  352. Serum and Uterine Concentrations of Cefazolin, Cefuroxime, and Ceftriaxone After Intraoperative Prophylactic Administration During Cesarean Section
  353. Effect of exogenous glutamate and N-Methyl-D-aspartic acid on spontaneous activity of isolated human ureter
  354. Pathogenic mechanisms in the development of surgical site infections
  355. Clinical pharmacology in Serbia: The time for new challenges
  356. Drug utilisation patterns in Zabljak municipality, Serbia and Montenegro
  357. Pharmacokinetic modelling of valproate from clinical data in Serbian epileptic patients
  358. Middle East conflicts: Basic features
  359. Inhibitory effects of selected antiepileptics on spontaneous motility of isolated human oviducts
  360. Characteristics of decision-making process during prescribing in general practice
  361. National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget
  362. Prevention of spreading of avian influenza in medical care facilities
  363. Impact of clinical pharmacology on health care: Serbian experience
  364. Population pharmacokinetics
  365. Clinical pharmacology in health care service
  366. Renal Adverse Effects of Interferon-??
  367. Effect of the exogenous glutamate and the NMDA on electric field-stimulated contractions of isolated rat ileum
  368. Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country
  369. Osnovi glutamatergicke neurotransmisije
  370. Mere za unapredjenje lekarske prakse
  371. Farmakologija receptora i celijskih transportera za glutamat
  372. Contractile effect of acetylcholine on isolated isthmic segment of fallopian tubes
  373. Contractile effect of acetylcholine on isolated ampullar segment of fallopian tubes
  374. Semi-Intensive Versus Intensive Monitoring of Adverse Drug Reactions in a Hospital
  375. Comparison of efficacy and safety between individualized and empiric dose regimen of amitriptyline in the treatment of major depressive episode
  376. Stimulating Spontaneous Reporting of Adverse Drug Reactions by a Patient
  377. Effect of intratumoral application of methotrexate in vivo on frequency of micronuclei in peripheral blood lymphocytes
  378. Slobodan Jankovic
  379. Whether use of antipsychotics in psychogeriatric facilities is appropriate?
  380. A pharmacological analysis of the contractile effects of glutamate on rat and human isolated gut smooth muscle strips
  381. Antipsychotic Drug Prescription in a Serbian Long-Stay Psychiatric Care Facility
  382. EFFECTS OF NICOTINE, DIMETHYLPHENYLPIPERAZINIUM AND TETRAMETHYLAMMONIUM ON SMOOTH MUSCLES FROM FELINE AND HUMAN GASTRIC CORPUS
  383. THE EFFECTS OF EXCITATORY AMINO ACIDS ON ISOLATED GUT SEGMENTS OF THE RAT
  384. A study of the effect of benzylpenicillin on isolated human gallbladder
  385. The control of hair growth
  386. DIFFERENCES IN THE EFFECTS OF VASOPRESSIN AND OXYTOCIN ON FELINE GASTRIC CORPUS MOTILITY: SELECTIVE ACTION OF VASOPRESSIN ON LONGITUDINAL MUSCLE